文献速递类风湿关节炎脊柱关节炎

2020年视角:类风湿关节炎与银屑病关节炎靶向及生物治疗期间的感染并发症

Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020.
PubMed 文献 · Ann Rheum Dis · 2020-09-22

本文为多学科专家基于2018年EULAR会议主题演讲形成的观点性总结,聚焦类风湿关节炎与银屑病关节炎患者接受靶向及生物治疗时感染并发症的免疫学基础与流行病学,并提供管理与预防的实用建议。

要点

  • 靶向及生物治疗相关感染风险因免疫靶点不同而异。
  • 需根据具体免疫靶点认识感染谱的多样性。
  • 专家提供感染管理与预防的实用指导。

核心结论

  • 靶向及生物治疗相关感染的发生与具体免疫靶点相关,感染谱因靶点不同而异。

研究设计与样本

  • 多学科专家基于2018年EULAR会议主题演讲形成的观点性总结。

主要发现

  • 针对细胞因子、可溶性介质、细胞表面分子或受体及细胞内信号通路组分的治疗可能与感染发生相关。

临床怎么用

  • 专家提供靶向及生物治疗期间感染管理与预防的实用指导。

局限性

  • 本文为观点性总结,非系统研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Biological therapies have improved the outcomes of several major inflammatory, autoimmune and also neoplastic disorders. Those directed towards cytokines or other soluble mediators, cell-surface molecules or receptors or various components of intracellular signalling pathways may be associated with the occurrence of infections whose diversity depends on the particular immune target. In this context and following a keynote lecture given by one of us at the European League Against Rheumatism meeting on June 2018, a multidisciplinary group of experts deeply involved in the use of targeted and biological therapies in rheumatoid and psoriatic arthritis decided to summarise their recent vision of the immunological basis and epidemiology of infections occurring during targeted and biological therapies, and provide useful indications for their management and prevention.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Lortholary O, Fernandez-Ruiz M, Baddley JW, et al. Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020. Ann Rheum Dis. 2020. PMID: 32963049. doi:10.1136/annrheumdis-2020-217092

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。